CHRISTINA ENGERT: Open Payments
NPI 1861142473 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 37 payments from 16 companies in 2025. Trend: 2023 $2,967 · 2024 $3,592 · 2025 $918
Food & beverage: $918
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $217 |
| Boston Scientific Corporation | 2 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $152 |
| QOL Medical, LLC | 3 | $57 |
| GENZYME CORPORATION | 1 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Madrigal Pharmaceuticals | 2 | $32 |
| PFIZER INC. | 2 | $30 |
| Intercept Pharmaceuticals, Inc. | 2 | $29 |
Products named: WATCHMAN FLX, ENTYVIO, DUPIXENT, Sucraid, XIFAXAN, CREON, ZENPEP, EOHILIA.
Industry payments across MO — which companies pay providers there.
